RxDoctor Payments Data

Stuart Hutchinson, MD

Orthopaedic Surgery of the Spine · Santa Barbara, CANPI 1922110329

Payments from drug & device makers

$801in general payments, 2019–2025

Across 44 payments — averaging $18.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$275
  • Electronic Waveform Lab, Inc.$212
  • Boston Scientific$81
  • Team_makena_llc$46
  • Fidia Pharma USA Inc.$35
  • Radius Health, Inc.$33
  • plus $118 from 5 others

What the payments were for

  • Food & beverage$801100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)8$275
Electronic Waveform Lab, Inc.24$212
Boston Scientific3$81
Team_makena_llc1$46
Fidia Pharma USA Inc.2$35
Radius Health, Inc.1$33
Globus Medical1$33
Almatica Pharma LLC1$28
Johnson & Johnson1$22
Si-bone, Inc.1$21
DJO, LLC1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$801 in reported general payments places this provider in the 15th percentile of 288 orthopaedic surgery of the spine providers in California.

See all orthopaedic surgery of the spine providers in California

Medicare billing

Part B allowed, 2024
$157,055
Medicare patients
352
Services billed
3,436

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lidocaine13$633
Diclofenac Sodium36$605
Gabapentin37$426
Cyclobenzaprine Hcl16$304
Meloxicam31$125
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen14$122

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Santa Barbara

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →